The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 22,065 515,788 SH   SOLE N/A 515,788 0 0
ACHILLION PHARMACEUTICALS IN COM 00448Q201 3,768 624,956 SH   SOLE N/A 624,956 0 0
ALLAKOS INC COM 01671P100 12,269 128,662 SH   SOLE N/A 128,662 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 18,046 841,714 SH   SOLE N/A 841,714 0 0
ARGENX SE SPONSORED ADR 04016X101 12,543 78,138 SH   SOLE N/A 78,138 0 0
ASCENDIS PHARMA A S SPONSORED ADR 04351P101 4,129 29,676 SH   SOLE N/A 29,676 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 10,005 161,949 SH   SOLE N/A 161,949 0 0
INSMED INC COM PAR $.01 457669307 23,617 988,999 SH   SOLE N/A 988,999 0 0
INTERSECT ENT INC COM 46071F103 1,998 80,238 SH   SOLE N/A 80,238 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 12,564 453,890 SH   SOLE N/A 453,890 0 0
KARYOPHARM THERAPEUTICS INC COM 48576U106 7,699 401,609 SH   SOLE N/A 401,609 0 0
KINIKSA PHARMACEUTICALS LTD COM CL A G5269C101 1,828 165,318 SH   SOLE N/A 165,318 0 0
NEOLEUKIN THERAPEUTICS INC COM 64049K104 9,980 810,073 SH   SOLE N/A 810,073 0 0
PROTEON THERAPEUTICS INC COM 74371L109 140 341,743 SH   SOLE N/A 341,743 0 0
ZOGENIX INC COM NEW 98978L204 24,338 466,875 SH   SOLE N/A 466,875 0 0